Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $50.8 million.

  • Icu Medical's Depreciation & Amortization (CF) fell 875.26% to $50.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.9 million, marking a year-over-year decrease of 928.7%. This contributed to the annual value of $219.5 million for FY2024, which is 404.85% down from last year.
  • Per Icu Medical's latest filing, its Depreciation & Amortization (CF) stood at $50.8 million for Q3 2025, which was down 875.26% from $49.7 million recorded in Q2 2025.
  • Icu Medical's 5-year Depreciation & Amortization (CF) high stood at $66.6 million for Q2 2022, and its period low was $22.2 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $55.3 million (2024), whereas its average is $48.6 million.
  • As far as peak fluctuations go, Icu Medical's Depreciation & Amortization (CF) soared by 20030.23% in 2022, and later tumbled by 1361.05% in 2023.
  • Icu Medical's Depreciation & Amortization (CF) (Quarter) stood at $23.1 million in 2021, then skyrocketed by 145.58% to $56.8 million in 2022, then increased by 0.61% to $57.2 million in 2023, then fell by 7.29% to $53.0 million in 2024, then decreased by 4.13% to $50.8 million in 2025.
  • Its last three reported values are $50.8 million in Q3 2025, $49.7 million for Q2 2025, and $49.4 million during Q1 2025.